Table Of Content

international journal of pharmaceutics +4 eh ie EVIER International Journal of Pharmaceutics 173 (1998) 263—264 Author index Barthe, L., M. Bessouet, J.F. Woodley, G. Houin, The improved Falson-Rieg, F., see Ganem-Quintanar, A. 173, 203 everted gut sac: a simple method to study intestinal P-glyco- Fang, J.-Y., Y.-B. Huang, H.-H. Lin, Y.-H. Tsai, Transdermal protein 173, 255 iontophoresis of sodium nonivamide acetate. IV. Effect of Bateman, S.R., see Butler, W.C.G. 173, 211 polymer formulations 173, 127 Bessouet, M., see Barthe, L. 173, 255 Faus, V., see Lopez, A. 173, 183 Blanco, D., see Torres, D. 173, 171 Forbes, A.E., see Haslam, J.L. 173, 233 Boado, L., see Torres, D. 173, 171 Bodmeier, R., see Chang, C.-M. 173, 51 Ganem-Quintanar, A., D. Quintanar-Guerrero, F. Falson-Rieg, Bridges, P.A., K.M.G. Taylor, Nebulisers for the generation of P. Buri, Ex vivo oral mucosal permeation of lidocaine liposomal aerosols 173, 117 hydrochloride with sucrose fatty acid esters as absorption Brodin, A., see Scherlund, M. 173, 103 enhancers 173, 203 Buri, P., see Ganem-Quintanar, A. 173, 203 Butler, W.C.G., S.R. Bateman, A flow-through dissolution Haslam, J.L., A.E. Forbes, G.S. Rork, T.L. Pipkin, D.A. Slade, method for a two component drug formulation where the D. Khossravi, Tableting of controlled release multiparticu- actives have markedly differing solubility properties 173, lates, the effect of mililisphere size and protective overcoat- 211 ing 173, 233 Herraez, M., see Lopez, A. 173, 183 Cartilier, L.H., see Moussa, I.S. 173, 35 Hino, T., see Kawashima, Y. 173, 243 Chang, C.-M., R. Bodmeier, Low viscosity monoglyceride- Houin, G., see Barthe, L. 173, 255 based drug delivery systems transforming into a highly Huang, Y.-B., see Fang, J.-Y. 173, 127 viscous cubic phase 173, 51 Hussain, M.A., see Chang, R.-K. 173, 87 Chang, R.-K., M. Shinwari, M. Leonzio, L.-S. Wu, J. Pang, M.A. Hussain, Evaluation of the disintegrant properties for Kachrimanis, K., G. Ktistis, $. Malamataris, Crystallisation an experimental, crosslinked polyalkylammonium poly- conditions and physicomechanical properties of ibuprofen mer 173, 87 Eudragit® $100 spherical crystal agglomerates prepared by the solvent-change technique 173, 61 Charman, S.A., see McCrossin, L.E. Kawashima, Y., T. Serigano, T. Hino, H. Yamamoto, H. Charman, W.N., see McCrossin, L.E. Takeuchi, Design of inhalation dry powder of pranlukast Codd, J.E., P.B. Deasy, Formulation development and in vivo hydrate to improve dispersibility by the surface modification evaluation of a novel bioadhesive lozenge containing a with light anhydrous silicic acid (AEROSIL 200) 173, 243 synergistic combination of antifungal agents 173, 13 Khossravi, D., see Haslam, J.L. 173, 233 Codd, J.E., P.B. Deasy, Synergistic antifungal interaction be- Ktistis, G., see Kachrimanis, K. 173, 61 tween miconazole nitrate and chlorhexidine acetate 173, 3 Corveleyn, S., J. Paul Remon, Bioavailability of hydrochloroth- Lastra, C.F., see Modamio, P. 173, 141 iazide: conventional versus freeze-dried tablets 173, 149 Lenaerts, V., see Moussa, I.S. 173, 35 Lennartz, P., J.B. Mielck, Minitabletting: improving the com- Deasy, P.B., see Codd, J.E. 173, 13 pactability of paracetamol powder mixtures 173, 75 Deasy, P.B., see Codd, J.E. 173, 3 Leonzio, M., see Chang, R.-K. 173, 87 Diez-Sales, O., see Lopez, A. 173, 183 Lin, H.-H., see Fang, J.-Y. 173, 127 Dyar, S.C., R.E. Notari, Hydrolysis kinetics and_ stability Lopez, A., V. Faus, O. Diez-Sales, M. Herraez, Skin permeation predictions for a mixture of R and S temocillin isomers 173, model of phenyl alcohols: comparison of experimental condi- 221 tions 173, 183 PIT 80378-5173(98)00276-2 264 Author index Ma, B., see Zhan, X. 173, 43 Scherlund, M., M. Malmsten, A. Brodin, Stabilization of a Malamataris, S., see Kachrimanis, K. 173, 61 thermosetting emulsion system using ionic and nonionic Malmsten, M., see Scherlund, M. 173, 103 surfactants 173, 103 Marino, E.L., see Modamio, P. 173, 141 Sentjurc, M., see Petelin, M. 173, 193 McCrossin, L.E., W.N. Charman, S.A. Charman, Degradation Serigano, T., see Kawashima, Y. 173, 243 of recombinant porcine growth hormone in the presence of Shinwari, M., see Chang, R.-K. 173, 87 guanidine hydrochloride 173, 157 Skaleri¢é, U., see Petelin, M. 173, 193 Mielck, J.B., see Lennartz, P. 173, 75 Slade, D.A., see Haslam, J.L. 173, 233 Miller, N.C., D.L. Ross, M.M. Nasr, Effect of formulation Steckel, H., B.W. Miller, Metered-dose inhaler formulation of factors on the observed bounce in cascade impactors used to fluticasone-17-propionate micronized with supercritical car- measure the spray particle size of metered dose inhalers 173, bon dioxide using the alternative propellant HFA-227 173, 93 25 Modamio, P., C.F. Lastra, E.L. Mario, Transdermal absorp- Stoli¢, Z., see Petelin, M. 173, 193 tion of celiprolol and bisoprolol in human skin in vitro 173, 141 Moussa, I.S., V. Lenaerts, L.H. Cartilier, Effect of some Takeuchi, H., see Kawashima, Y. 173, 243 physical parameters on the swelling properties of cross-linked Taylor, K.M.G., see Bridges, P.A. 173, 117 amylose matrices 173, 35 Torres, D., L. Boado, D. Blanco, J.L. Vila-Jato, Comparison Miiller, B.W., see Steckel, H. between aqueous and non-aqueous solvent evaporation methods for microencapsulation of drug—resin com- Nasr, M.M., see Miller, N.C. 173, 93 plexes 173, 171 Notari, R.E., see Dyar, S.C. 173, 221 Tsai, Y.-H., see Fang, J.-Y. 173, 127 Pang, J., see Chang, R.-K. 173, 87 Vila-Jato, J.L., see Torres, D. 173, 171 Paul Remon, J., see Corveleyn, S$. 173, 149 Petelin, M., M. Sentjurc, Z. Stolit, U. Skaleri¢, EPR study of Woodley, J.F., see Barthe, L. 173, 5 55 mucoadhesive ointments for delivery of liposomes into the Wu, L.-S., see Chang, R.-K. 173, 8 / oral mucosa 173, 193 Pipkin, T.L., see Haslam, J.L. 173, 233 Yamamoto, H., see Kawashima, Y. 173, 243 Yin, G., see Zhan, X. 173, 43 Quintanar-Guerrero, D., see Ganem-Quintanar, A. 173, 203 Zhan, X., G. Yin, B. Ma, Improved stability of 25% vitamin C Rork, G.S., see Haslam, J.L. parenteral formulation 173, 43 Ross, D.L., see Miller, N.C. 173, 93